Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LARGE-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PTPN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PDE5A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC4D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FZD10-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505782 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLNC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6513 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNPTAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP4F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EMX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on